Search

Panacea Biotec

Sector: Healthcare | Industry: Drugs & Pharma
R 157.95 -1.05  | -0.66% -35.99% - 961.94
NSE Price: Nov 16, 15:53 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Nov 16, 15:53 157.95 -1.05 -0.66% 158.65 159.00 9,295 156.60 - 160.70
BSE Nov 16, 2018 157.05 -2.25 -1.41% 158.65 159.30 4,897 157.00 - 160.65
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE FREE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 74,559 P/B: 3.83 NSE Code: PANACEABIO
52-Week Range: R 140.95 - 364.35 Dividend Yield: 0.00% BSE Code: 531349
TTM EPS: R -24.91 Book Value: R 41.03 Face Value: R 1
Price Graph
  • Merck (NSE)
  • NIFTY 50


Please wait while we are fetching data...
Get the best stock ideas
Want to create meaningful wealth through stock investing? Subscribe to Wealth Insight
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Panacea Biotec -35.00 -6.81 -30.08 -35.99 5.35 8.96 1.31
NIFTY Smallcap 100 -31.30 0.22 -16.14 -25.22 5.54 15.07 13.76
NIFTY Pharma -3.31 -5.44 -3.06 2.41 -7.39 4.50 14.89
Company's return has been calculated on basis of NSE's price.
As on Nov 16, 2018
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 8.97 -4.81 -0.52
Net Profit -34.95 7.91 10.86
EPS -35.78 9.28 10.99
Book Value -13.21 311.05 8.14
Average
Operating Margin 15.65 17.70 10.11
Net Margin -12.68 -8.45 -12.22
Return on Networth -22.94 -19.11 -77.37
Return on Investment 2.63 5.11 3.83
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue 24.68 -22.28 -29.23
Operating Profit 53.60 -118.01 -120.42
Net Profit -164.70 -1,631.62 -1,040.23
EPS -164.70 -1,631.69 -1,040.22
TTM
Revenue -5.99 -0.74 -8.02
Operating Profit -50.74 -57.12 -55.22
Net Profit -151.28 -51.31 -112.27
EPS -151.29 -51.31 -112.27
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Panacea Biotec 961.94 533.41 -152.58 -27.51 -22.94 3.83 -
Astrazeneca Pharma India 4,147.88 602.06 8.39 1.37 11.12 15.74 494.15
Merck 5,025.21 1,051.73 150.62 11.53 13.44 6.17 40.55
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Sep 04, 2018 Rajesh Jain HUF  Sell Market 266,665 241.95 645.20
Sep 04, 2018 Rajesh Jain HUF  Sell Market 29,153 241.95 70.54
Apr 06, 2018 Ashwani Jain  Sell Market 21,360 303.55 64.84
Mar 28, 2018 Serum Institude Of India Pvt Ltd  Buy Open Market 320,137 267.15 855.25
Mar 19, 2018 Sunanda Jain  Buy Transmission 5,712,300 279.85 15,985.87
Fund Houses invested in the stock
Fund Sep-18 Jun-18 Mar-18 Dec-17 Sep-17
ICICI Prudential Mutual Fund 1.007 - - - -
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Panacea Biotec Ltd.

Address: Ambala - Chandigarh Highway, Lalru, Punjab - 140501 | Phone: 01762- 505900 | Fax: 01762- 505909 / 505906

Email: [email protected]

Website: www.panacea-biotec.com

Registrar & Transfer Agent: Skyline Financial Services Pvt Ltd

Address: D-153/A, 1st Floor,Okhla Industrial Area, Phase - I, New Delhi - 110020, D-153/A, 1st Floor, Okhla Industrial Area, Phase - I | Phone: 91-011-26812682/84 | Fax: 91-11-26292681

Email: [email protected]

comments powered by Disqus
Essential checks
Altman Z-Score
0.87
Piotroski F-Score
4
Modified C-Score
2
5-Years Price to Earnings
Not applicable
5-Years Price to Book
2.74
Earnings Yield
EBIT / Enterprise value
-2.03%
PEG
Price / Earnings to growth ratio
Not available
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R1,666.85 -1.40%
Caplin Point Laboratories R423.75 -1.55%
Dishman Carbogen Amcis R231.95 +1.98%
FDC R190.20 -1.14%
JB Chemicals & Pharma R308.55 -0.03%
Laurus Labs R399.15 +4.42%
Merck R3,023.70 +0.80%
Shilpa Medicare R389.20 +4.09%
Strides Pharma Science R464.65 +1.51%
Suven Life Sciences R247.80 -3.30%
As on Nov 16, 15:59